Cardiovascular regulation by L-arginine in the brain of rats. Role of the brain renin-angiotensin system and nitric oxide

American Journal of Hypertension

Volumn 10, Issue 4 I, 1997, Pages 389-396

  Nishimura, Masato ^a   Takahashi, Hakuo ^b   Nanbu, Akira ^b   Sakamoto, Masatoshi ^b   Yoshimura, Manabu ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NONE

Author keywords

angiotensin II; central nervous system; D arginine; L arginine; nitric oxide; sympathetic nervous activity

Indexed keywords

ARGININE; BUNAZOSIN; DEXTRO ARGININE; N(G) METHYLARGININE; NITRIC OXIDE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BRAIN; CONTROLLED STUDY; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030906458     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00401-3     Document Type: Article

References (22)

1. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
2. Gardiner SM, Compton AM, Bennett T, et al: Control of regional blood flow by endothelium-derived nitric oxide. Annu Rev Pharmacol 1990;15:486-492.
3. Rees DD, Palmer RMJ, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-3378.
4. Nakaki T, Hishikawa K, Suzuki H, et al: L-Arginine-induced hypotension. Lancet 1990;336:696.
5. G-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 1989;160:881-886.
6. Fineman JR, Chang R, Soifer SJ: L-Arginine, a precursor of EDRF in vitro, produces pulmonary vasodilatation in lambs. Am J Physiol 1991;261:H1563-H1569.
7. Takemoto Y: Amino acids with central pressor effect in conscious rats, Jpn J Physiol 1990;40:561-565.
8. Mollace V, DeFrancesco EA, Nistico G: Evidence that pharmacological manipulations of central L-argininc-NO pathway influence blood pressure and heart rate in rats. Neurosci Lett 1992;13:787-790.
9. G-nitro-L-arginine. Eur J Pharmacol 1991; 198:183-188.
10. Nishimura M., Takahashi H, Matsusavva M, et al: The effects of insulin-like materials in the brain on central cardiovascular regulation: with special reference to the central effects of sodium chloride. J Hypertens 1991; 9:509-517.
11. G-dimethylarginine from the hydrolysate of proteins of bovine brain. Biochim Biophys Acta 1971; 230:212-222.
12. Shibouta Y, Inada Y, Ojima M, et al: Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[2′-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (±)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). J Pharmacol Exp Ther 1993;266:114-120.
13. 1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 1991;178:707-712.
14. Togashi H, Sakuma I, Yoshioka M, et al: A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 1992;262:343-347.
15. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990;347:768-770.
16. Vincent SR, Kimura H: Histological mapping of nitric oxide synthase in the rat brain. Neuroscience 1992, 46:755-784.
17. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988;336:385-388.
18. Lewis SJ, Machado B, Ohta H, et al: Cardiovascular effects of the EDRF candidate S-nitrosocysteine microinjected into the nucleus tractus solitarius of rats (abst). FASEB J 1991;5:A1411.
19. Shapoval LN, Sagach VF, Pobegailo LS: Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 1991; 132:47-50.
20. Mitchell RH, Kirk CJ, Billah MM: Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans 1979;7:861-865.
21. Nishimura M, Milsted A, Block CH, et al: Tissue reninangiotensin systems in renal hypertension. Hypertension 1992;20:158-167.
22. Hoeprich PD: Demonstration of D-alanine in the serum of guinea pigs and mice. J Biol Chem 1965;240:1654-1660.